Literature DB >> 7507032

Meta-analysis. A review of its place in therapeutic decision making.

M Gibaldi1.   

Abstract

The potential value of meta-analysis has captured the imagination of many investigators. Epidemiologists have, appropriately, greeted its broad application with considerable caution, yet practical matters, such as the need to consolidate and extract information from available data, have forced a more accepting approach. Meta-analysis has been employed in many clinical settings to evaluate efficacy and safety of a variety of therapeutic interventions. It is likely that it will continue to have a role in extrapolating data from clinical trials for use in the clinic.

Mesh:

Year:  1993        PMID: 7507032     DOI: 10.2165/00003495-199346050-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  40 in total

Review 1.  Hypertension in pregnancy.

Authors:  F G Cunningham; M D Lindheimer
Journal:  N Engl J Med       Date:  1992-04-02       Impact factor: 91.245

Review 2.  Overview of the management of thrombotic disorders.

Authors:  A S Gallus
Journal:  Semin Thromb Hemost       Date:  1989-04       Impact factor: 4.180

3.  Can meta-analyses be trusted?

Authors:  S G Thompson; S J Pocock
Journal:  Lancet       Date:  1991-11-02       Impact factor: 79.321

4.  A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer.

Authors:  K K Steinberg; S B Thacker; S J Smith; D F Stroup; M M Zack; W D Flanders; R L Berkelman
Journal:  JAMA       Date:  1991-04-17       Impact factor: 56.272

5.  The medical review article: state of the science.

Authors:  C D Mulrow
Journal:  Ann Intern Med       Date:  1987-03       Impact factor: 25.391

6.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

7.  Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome.

Authors:  U Ravnskov
Journal:  BMJ       Date:  1992-07-04

8.  A method for assessing the quality of a randomized control trial.

Authors:  T C Chalmers; H Smith; B Blackburn; B Silverman; B Schroeder; D Reitman; A Ambroz
Journal:  Control Clin Trials       Date:  1981-05

9.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R Kleiger; J P Miller; L M Rolnitzky
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

10.  Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis.

Authors:  A K Burroughs; W J Jenkins; S Sherlock; A Dunk; R P Walt; T O Osuafor; S Mackie; R Dick
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

View more
  5 in total

Review 1.  A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.

Authors:  A K Gupta; N H Shear
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

2.  Effect of diacylglycerol supplementation on fasting serum triacylglycerol concentration: a meta-analysis.

Authors:  Wenliang Wang; Tongcheng Xu; Xia Li; Qingjun Zhu; Anwei Cheng; Fangling Du; Duo Li
Journal:  Lipids       Date:  2010-11-13       Impact factor: 1.880

Review 3.  The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia.

Authors:  S Ulrich; C Wurthmann; M Brosz; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

4.  Effect of diacylglycerol on postprandial serum triacylglycerol concentration: a meta-analysis.

Authors:  Tongcheng Xu; Xia Li; Xiaohang Ma; Zhiguo Zhang; Tiansong Zhang; Duo Li
Journal:  Lipids       Date:  2008-11-07       Impact factor: 1.880

5.  Serial changes in plasma levels of cytokines in patients with coronary artery disease.

Authors:  Roberto H Heinisch; Carlos R Zanetti; Fabiano Comin; Juliano L Fernandes; José A Ramires; Carlos V Serrano
Journal:  Vasc Health Risk Manag       Date:  2005
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.